Validation continues to be incredibly strong. Importantly this unlocks a broader range of use cases which increases the commercial opportunity.
Ann: Outstanding Results Achieved in Second JHC Clinical Trial, page-4
Add HMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
-0.003(13.0%) |
Mkt cap ! $15.75M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 1.8¢ | $58.21K | 2.832M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 893566 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 150000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| HMD (ASX) Chart |